Pump it up

This growing Houston company is revolutionizing the way new mothers pump in the office

Houston-based Work & Mother is rethinking how new mothers pump in the office. Courtesy of Work & Mother

A new mom returning to work is probably dreading her new daily inconvenience of taking the time out of the workday to pump her breast milk.

While some employers provide a wellness room to us, but the more likely scenario is that she will have to pump in your car, an empty conference room or the bathroom. And once she is done pumping, she'll have to wash her equipment in the kitchen sink, alongside her coworkers' coffee mugs or dirty Tupperware containers.

One newly launched company mission is to make that scenario a thing of the past.

Work & Mother is a boutique pumping and wellness center that opened its first location in downtown Houston in 2017 and is planning its second downtown location. The 600-square-foot space opened on the first floor of 712 Main St. and offers memberships to companies and individuals, regardless of whether they work in the building.

Abbey Donnell founded the company after speaking with friends who recently returned to work after giving birth.

"There were constant stories about [women] being told the use the IT closet, or the conference room, or the bathroom or their cars," Donnell says. "Some of them were pretty big oil and gas firms companies that should've had the resources and space to do better than that."

Work & Mother offers its members several private pumping rooms, private pumping office spaces, a kitchen area, member lockers and a small retail section where members can buy pumping and wellness equipment. The company's pitch to individual mothers is simple: come to us for privacy and community. But its pitch to companies is more rooted in regulations.

Per the Fair Labor Standards Act Section 7(r), companies with 50 or more employees are required to provide "a place, other than a bathroom, that is shielded from view and free from intrusion from coworkers and the public, which may be used by an employee to express breast milk." Companies that aren't in compliance with Section 7(r) — and lack the resources to do so — can either purchase individual or company memberships to Work & Mother.

"The reception from moms has been incredible," Donnell says. "I've gotten a lot of support from women who are older in their fields, who talk about how [pumping in the office] was a horrible experience for them."

Work & Mother is planning its second location, which will also be in downtown Houston, but Donnell declined to share additional details. When she started the company in 2017, she took minimal investments from friends and family, she says. But in anticipation of the company's second location, Work & Mother will likely launch a pre-seed fundraising round this summer, Donnell says. No financial figures have been finalized, but Donnell says the tentative plan is to raise roughly $1 million.

The company is also hoping to open in cities such as Chicago, New York, Austin, and Dallas in the near future.

Work & Mother isn't targeting companies that are solely concerned about meeting Section 7(r) compliance, Donnell says. Rather, she's hoping to show companies that investing in the well-being of new mothers is essential to running a successful business – and it's the right thing to do.

"If there's an employer who really only cares about the compliance, then they're not exactly a good fit, because they'll convert a closet and check that box," Donnell says.

But what Donnell says she's found refreshing is that most of the companies she's interacted with have had great feedback for her. They're trying to recruit — and retain — top female talent, she says.

More soon

Courtesy of Work & Mother

Donnell has plans for a second Houston location, as well as an expansion to other major United States cities.

Trending News

Building Houston

 
 

A new AI-optimized COVID screening device, a free response resource, and more — here's your latest roundup of research news. Image via Getty Images

Researchers across the Houston area are working on COVID-19 innovations every day, and scientists are constantly finding new ways this disease is affecting humankind.

From a COVID breathalyzer to a new collaboration in Houston — here's your latest roundup of local coronavirus research news.

A&M System to collaborate on a COVID-19 breathalyzer

A prototype of the device will be used on the Texas A&M campus. Photo via tamu.edu

Researchers at Texas A&M University System are collaborating on a new device that uses artificial intelligence in a breathalyzer situation to detect whether individuals should be tested for COVID-19. The technology is being developed through a collaboration with Dallas-based company, Worlds Inc., and the U.S. Air Force.

The device is called Worlds Protect and a patient can use a disposable straw to blow into a copper inlet. In less than a minute, test results can be sent to the person's smartphone. Worlds Inc. co-founders Dave Copps and Chris Rohde envision Worlds Protect kiosks outside of highly populated areas to act as a screening process, according to a news release.

"People can walk up and, literally, just breathe into the device," says Rohde, president of Worlds Inc., in the release. "It's completely noninvasive. There's no amount of touching. And you quickly get a result. You get a yay or nay."

The university system has contributed $1 million in the project's development and is assisting Worlds Inc. with engineering and design, prototype building and the mapping of a commercial manufacturing process. According to the release, the plan was to test the prototypes will be tried out this fall on the Texas A&M campus.

"Getting tech innovations to market is one of our sweet spots," says John Sharp, chancellor of the Texas A&M System, in the release. "This breakthrough could have lasting impact on global public health."

Baylor College of Medicine researchers to determine cyclosporine’s role in treating hospitalized COVID-19 patients

BCM researchers are looking into the treatment effect of an existing drug on COVID-19 patients. Photo via BCM.edu

The Baylor College of Medicine has launched a randomized clinical trial to look into how the drug cyclosporine effects the prevention of disease progression in pre-ICU hospitalized COVID-19 patients. The drug has been used for about 40 years to prevent rejection of organ transplants and to treat patients with rheumatoid arthritis and psoriasis.

"The rationale is strong because the drug has a good safety profile, is expected to target the body's hyperimmune response to COVID and has been shown to directly inhibit human coronaviruses in the lab," says Dr. Bryan Burt, chief of thoracic surgery in the Michael E. DeBakey Department of Surgery at Baylor, says in a press release.

Burt initiated this trial and BCM is the primary site for the study, with some collaboration with Brigham and Women's. The hypothesis is that the drug will help prevent the cytokine storm that patients with COVID-19 experience that causes their health to decline rapidly, according to the release.

The study, which is funded by Novartis, plans to enroll 75 hospitalized COVID-19 patients at Baylor St. Luke's Medical Center who are not in the ICU. There will be an initial evaluation at six months but Burt expects to have the final study results in one year.

Rice launches expert group to help guide pandemic response

A new response team is emerging out of a collaboration led by Rice University. Photo courtesy of Rice

Rice University is collaborating with other Houston institutions to create the Biomedical Expert Panel, supported by Texas Policy Lab, to assist officials in long-term pandemic recovery.

"Not all agencies and decision-makers have an in-house epidemiologist or easy access to leaders in infectious disease, immunology and health communications," says Stephen Spann, chair of the panel and founding dean of the University of Houston College of Medicine, in a news release. "This panel is about equity. We must break out of our knowledge siloes and face this challenge together, with a commitment to inclusivity and openness."

The purpose of the panel is to be available as a free resource to health departments, social service agencies, school districts and other policymakers. The experts will help design efficient public health surveillance plans, advise on increasing testing capacity and access for underserved communities, and more.

"The precise trajectory of the local epidemic is difficult to predict, but we know that COVID-19 will continue to be a long-term challenge," says E. Susan Amirian, an epidemiologist who leads the TPL's health program, in the release. "Although CDC guidelines offer a good foundation, there is no one-size-fits-all approach when managing a crisis of this magnitude across diverse communities with urgent needs."

Trending News